Position in AZN
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$538,520
-$10,540 QoQ
Shares Held
2,840
+2.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.45%
of 13F equity value
Holder Rank
#835
of 1,459 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 55%
Shared 0%
None 45%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Alhambra Investment Management LLC holds $9,363,953 across 10 Drug Manufacturers - General names. AZN ranks #7 (5.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
8,705 | $2,210,808 | |
| 2 | AMGN |
Amgen Inc
|
4,329 | $1,567,617 | |
| 3 | MRK |
Merck & Co., Inc.
|
10,112 | $1,299,392 | |
| 4 | LLY |
ELI LILLY & Co
|
1,067 | $1,279,791 | |
| 5 | NVS |
Novartis AG
|
5,321 | $833,907 | |
| 6 | ABBV |
AbbVie Inc.
|
2,924 | $735,795 | |
| 7 | AZN |
Astrazeneca PLC
This page
|
2,840 | $538,520 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
7,185 | $413,999 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $538,520 | 2,840 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $549,060 | 2,784 | Shares | Sole | 2026-04-15 | |
| No filing history on record for this holder in this stock. | ||||||